Summer Program for Academic Research in Cancer (SPARC)
癌症学术研究暑期项目 (SPARC)
基本信息
- 批准号:10628221
- 负责人:
- 金额:$ 29.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-13 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdvocacyBenchmarkingCancer BiologyCancer BurdenCancer ControlCareer ChoiceClinicalClinical ResearchClinical TrialsCommunicationCommunitiesCommunity OutreachComprehensive Cancer CenterCountryDedicationsDevelopmentDoctor of PhilosophyEducationEducational workshopEligibility DeterminationEnrollmentEnsureEvaluationEventExtramural ActivitiesFundingFutureGoalsHigh School FacultyHigh School StudentHomeImmunooncologyIndianaInstitutionInterventionKnowledgeLaboratoriesLaboratory ResearchLeadershipMalignant NeoplasmsManuscriptsMedicalMedical StudentsMentorsMethodsMissionNCI-Designated Cancer CenterOsteopathic MedicinePathway interactionsPatient CarePhysiciansPostbaccalaureatePrecision therapeuticsPrevention strategyPrincipal InvestigatorProductivityProgram EvaluationQuestionnairesRecommendationRecording of previous eventsResearchResearch PersonnelResource-limited settingResourcesScholarshipScienceScientistSocietiesSourceStructureStudentsSystemTrainingTraining ActivityUnderrepresented PopulationsUnderrepresented StudentsUniversitiesWritingacademic programanticancer researchcancer educationcancer preventioncareercareer developmentcollegecommunity engagementdesigndrug discoveryeleventh gradeexperiencegraduate studenthigh schoolhigh school programimprovedlecturesmedical schoolsmeetingsmembernext generationoutreachpeer coachingprogramspublic health emergencyrecruitskillsstudent trainingsuccesssummer programsummer researchtumorundergraduate educationundergraduate research experienceundergraduate studentvirtual
项目摘要
The objective of the proposed Summer Program for Academic Research in Cancer (SPARC) at the Indiana
University Simon Comprehensive Cancer Center (IUSCCC) is to provide cancer research career pathways for
undergraduate and medical students. This objective will be achieved by providing mentored, high-quality, cancer-
focused research experiences along with didactic and professional development workshops to undergraduate
and first year medical students to prepare them for cancer-related fields. Twenty-five trainees (15 undergraduate
and 10 first-year medical students) will be recruited every year to spend 10 weeks performing cancer research
and attend didactic and professional development workshops, clinical shadowing with physician-scientist
mentors in case of medical student trainees, and networking events. SPARC is open to any eligible student
across the country with a residential option for some, but we anticipate the majority of undergraduate students
to come from major universities in Indiana including Indiana University, University of Indianapolis, Indiana State
University, Purdue University, and the University of Notre Dame, whereas medical students are likely to be from
IU School of Medicine, the only allopathic medical school in Indiana, and potentially from Marian University
College of Osteopathic Medicine. While undergraduate trainees will potentially become graduate students in the
new translational cancer biology PhD program, medical trainees can become part of our recently established
Scholarly Concentration in Cancer Biology Research and Practice. Sixty five IUSCCC investigators with previous
history of productive mentoring of undergraduate and medical students during summers and active extramurally
funded research programs will serve as mentors. Project trainees will gain enhanced laboratory and research
skills, including appreciation of the cancer research enterprise and patient care, understanding of career
opportunities, and a long-term academic relationship with mentors. Didactic lectures include basic cancer
biology, immuno-oncology, and precision therapy, and professional workshops include career opportunities,
communicating science, manuscript writing, and tumor board to round out the summer experience. An
administrative structure consisting of a principal investigator with administrative and mentoring experience, co-
investigators with program implementation, mentoring, and program evaluation experience, and a program
manager with recruitment and community outreach experience has been established along with program
assessment/refinement by internal and external advisors. A virtual summer research experience in cancer, which
we designed and implemented in 2020, will be implemented in years where public health emergencies preclude
hands-on training. SPARC continues the success of IUSCCC in administering summer research programs for
the past 20 years and expands the scope to fulfill the mission of the IUSCCC to educate students from a diverse
educational spectrum who will become ambassadors for cancer knowledge and research in their communities
and eventually become biomedical professionals who help in reducing cancer burden.
拟议的印第安纳州癌症学术研究暑期项目的目标
西蒙大学综合癌症中心(IUSCCC)是提供癌症研究的职业途径,
本科生和医学生。这一目标将通过提供指导,高质量,癌症-
重点研究经验,沿着教学和专业发展研讨会,以本科生
和一年级医学生,为他们进入癌症相关领域做准备。25名受训人员(15名本科生
和10名一年级医学生)将被招募,每年花10周时间进行癌症研究
并参加教学和专业发展研讨会,与医生-科学家一起进行临床跟踪
在医科学生受训的情况下提供指导,并开展网络活动。该课程对任何符合条件的学生开放
全国各地的一些住宿选择,但我们预计大多数本科生
来自印第安纳州的主要大学,包括印第安纳州大学、印第安纳波利斯大学、印第安纳州
大学,普渡大学和圣母大学,而医学院的学生很可能来自
IU医学院,印第安纳州唯一的对抗疗法医学院,并可能从玛丽安大学
骨科医学院。虽然本科学员将有可能成为研究生,
新的转化癌症生物学博士课程,医学学员可以成为我们最近成立的
癌症生物学研究和实践的学术浓度。65名IUSCCC研究者,
本科生和医学生在暑期和积极的校外生产辅导的历史
受资助的研究项目将担任导师。项目学员将获得增强的实验室和研究
技能,包括对癌症研究企业和病人护理的欣赏,对职业的理解
机会,以及与导师的长期学术关系。教学讲座包括基础癌症
生物学,免疫肿瘤学和精确治疗,专业研讨会包括职业机会,
交流科学,手稿写作和肿瘤委员会,以完成夏季的经验。一个
行政结构,包括一名具有行政和指导经验的主要调查员,
具有项目实施、指导和项目评估经验的调查人员,以及一个项目
已沿着建立了一名具有招聘和社区外展经验的经理,
内部和外部顾问的评估/改进。一个虚拟的夏季癌症研究体验,
我们在2020年设计和实施的,将在公共卫生紧急情况排除的年份实施
动手训练。IUSCCC继续成功管理夏季研究计划,
在过去的20年里,扩大了范围,以履行IUSCCC的使命,教育学生从不同的
他们将成为社区癌症知识和研究的大使
并最终成为帮助减轻癌症负担的生物医学专业人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harikrishna Nakshatri其他文献
Harikrishna Nakshatri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harikrishna Nakshatri', 18)}}的其他基金
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10515659 - 财政年份:2015
- 资助金额:
$ 29.58万 - 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10296651 - 财政年份:2015
- 资助金额:
$ 29.58万 - 项目类别:
Mechanisms associated with systemic effects of cancer
与癌症全身效应相关的机制
- 批准号:
10043823 - 财政年份:2015
- 资助金额:
$ 29.58万 - 项目类别:
Estrogen-Estrogen Receptor axis in non-transformed breast epithelial cells: studies beyond MCF-7
非转化乳腺上皮细胞中的雌激素-雌激素受体轴:MCF-7 以外的研究
- 批准号:
9024970 - 财政年份:2015
- 资助金额:
$ 29.58万 - 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
- 批准号:
8113776 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
- 批准号:
8240038 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
Persistent microRNA changes in serum of cancer-free breast cancer patients
无癌乳腺癌患者血清中持续的 microRNA 变化
- 批准号:
8104694 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
Anthrax Toxin Receptor as a marker and target of breast cancer stem cells
炭疽毒素受体作为乳腺癌干细胞的标记和靶标
- 批准号:
8244440 - 财政年份:2011
- 资助金额:
$ 29.58万 - 项目类别:
相似国自然基金
企业绩效评价的DEA-Benchmarking方法及动态博弈研究
- 批准号:70571028
- 批准年份:2005
- 资助金额:16.5 万元
- 项目类别:面上项目
相似海外基金
An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
- 批准号:
10100319 - 财政年份:2024
- 资助金额:
$ 29.58万 - 项目类别:
Collaborative R&D
BioSynth Trust: Developing understanding and confidence in flow cytometry benchmarking synthetic datasets to improve clinical and cell therapy diagnos
BioSynth Trust:发展对流式细胞仪基准合成数据集的理解和信心,以改善临床和细胞治疗诊断
- 批准号:
2796588 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Studentship
Elements: CausalBench: A Cyberinfrastructure for Causal-Learning Benchmarking for Efficacy, Reproducibility, and Scientific Collaboration
要素:CausalBench:用于因果学习基准测试的网络基础设施,以实现有效性、可重复性和科学协作
- 批准号:
2311716 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Benchmarking collisional rates and hot electron transport in high-intensity laser-matter interaction
高强度激光-物质相互作用中碰撞率和热电子传输的基准测试
- 批准号:
2892813 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Studentship
Collaborative Research: SHF: Medium: A Comprehensive Modeling Framework for Cross-Layer Benchmarking of In-Memory Computing Fabrics: From Devices to Applications
协作研究:SHF:Medium:内存计算结构跨层基准测试的综合建模框架:从设备到应用程序
- 批准号:
2347024 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Standard Grant
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
- 批准号:
2233969 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant
FET: Medium: Quantum Algorithms, Complexity, Testing and Benchmarking
FET:中:量子算法、复杂性、测试和基准测试
- 批准号:
2311733 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant
Establishing and benchmarking advanced methods to comprehensively characterize somatic genome variation in single human cells
建立先进方法并对其进行基准测试,以全面表征单个人类细胞的体细胞基因组变异
- 批准号:
10662975 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Collaborative Research: BeeHive: A Cross-Problem Benchmarking Framework for Network Biology
合作研究:BeeHive:网络生物学的跨问题基准框架
- 批准号:
2233968 - 财政年份:2023
- 资助金额:
$ 29.58万 - 项目类别:
Continuing Grant